tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
:NWBO
US Market

Northwest Biotherapeutics (NWBO) Income Statement

Compare
476 Followers

Northwest Biotherapeutics Income Statement

Last quarter (Q3 2024), Northwest Biotherapeutics's total revenue was $357.00K, a decrease of -12.07% from the same quarter last year. In Q3, Northwest Biotherapeutics's net income was $-19.37M. See Northwest Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.93M$ 1.68M$ 1.00M$ 1.29M$ 2.41M
Gross Profit
$ -25.80M$ 135.00K$ -19.30M$ -32.35M$ -11.70M
Operating Expenses
$ 57.44M$ 68.86M$ 53.71M$ 87.90M$ 29.87M
Depreciation and Amortization
$ 1.73M$ 1.55M$ 586.00K$ 425.00K$ 21.00K
EBITDA
$ -55.34M$ -97.42M$ 184.72M$ -520.85M$ -17.82M
Operating Income
$ -55.51M$ -67.18M$ -52.70M$ -86.61M$ -27.46M
Other Income/Expenses
$ -7.09M$ -37.85M$ 231.83M$ -443.22M$ 7.17M
Pretax Income
$ -62.60M$ -105.03M$ 179.13M$ -529.82M$ -20.30M
Net Income
$ -62.60M$ -136.85M$ 179.13M$ -538.37M$ -23.57M
Per Share Metrics
Basic EPS
$ -0.06$ -0.13$ 0.21$ -0.74$ -0.04
Diluted EPS
$ -0.06$ -0.13$ -0.06$ -0.74$ -0.04
Weighted Average Shares Outstanding
1.12B 1.02B 873.52M 725.13M 564.19M
Weighted Average Shares Outstanding (Diluted)
1.12B 1.02B 1.01B 725.13M 564.19M
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis